World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
18422
World Ranking
4375
National Ranking
1984

Zizhang Sheng publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Zizhang Sheng sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 105 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Zizhang Sheng D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Zizhang Sheng sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Zizhang Sheng is affiliated with Columbia University in the United States. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Molecular Biology, Immunology, and Radiology, Nuclear Medicine and Imaging. Their work involves extensive investigation into viral infections and immune response mechanisms.

Sheng has contributed significantly to topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • HIV Research and Treatment
  • SARS-CoV-2 detection and testing
  • Viral gastroenteritis research and epidemiology

The scientist has collaborated frequently with several researchers, notably:

  • Yicheng Guo (61 coauthored publications)
  • Lawrence Shapiro (47 coauthored publications)
  • David D. Ho (41 coauthored publications)
  • Lihong Liu (35 coauthored publications)
  • Yaoxing Huang (35 coauthored publications)

Sheng's work has been published most often in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory), 24 publications
  • Nature, 8 publications
  • EMPIAR dataset, 8 publications
  • Cell Reports, 5 publications
  • Cell Host & Microbe, 4 publications

Among their recent papers are:

  • "Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike," 2020, Nature
  • "Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2," 2021, Nature
  • "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants," 2022, Cell
  • "Antibody evasion properties of SARS-CoV-2 Omicron sublineages," 2022, Nature
  • "Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5," 2022, Nature

Best Publications

  • Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

    Unknown

  • Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

    Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

    Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu

  • Antibody evasion properties of SARS-CoV-2 Omicron sublineages

    Unknown

  • Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

    Unknown

  • Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

    Unknown

  • Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

    Unknown

  • Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.

    Gabriele Cerutti;Yicheng Guo;Tongqing Zhou;Jason Gorman

  • SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion

    Unknown

  • Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses.

    Ben M. Hause;Mariette F Ducatez;Emily A. Collin;Zhiguang Ran

  • Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family

    Ben M. Hause;Emily A. Collin;Runxia Liu;Bing Huang

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

    Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

    K. Xu;P. Acharya;R. Kong;C. Cheng

  • Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

    Xueling Wu;Xueling Wu;Zhenhai Zhang;Chaim A. Schramm;M. Gordon Joyce

  • Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

    Ming Tian;Ming Tian;Cheng Cheng;Xuejun Chen;Hongying Duan

  • Cocirculation of Two Distinct Genetic and Antigenic Lineages of Proposed Influenza D Virus in Cattle

    Emily A. Collin;Emily A. Collin;Zizhang Sheng;Yuekun Lang;Wenjun Ma

  • Cryo-EM structure of the SARS-CoV-2 Omicron spike

    Unknown

  • A Novel SARS-CoV-2 Variant of Concern, B.1.526, Identified in New York

    Medini K Annavajhala;Hiroshi Mohri;Pengfei Wang;Manoj S Nair

  • Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection.

    Takuya Yamamoto;Rebecca M. Lynch;Rajeev Gautam;Rodrigo Matus-Nicodemos

  • Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

    David Ho;Pengfei Wang;Lihong Liu;Sho Iketani

  • Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.

    Medini K. Annavajhala;Hiroshi Mohri;Pengfei Wang;Manoj Nair

  • Analysis of immunoglobulin transcripts and hypermutation following SHIV AD8 infection and protein-plus-adjuvant immunization

    Joseph R. Francica;Zizhang Sheng;Zhenhai Zhang;Yoshiaki Nishimura

  • Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

    R. Kong;H. Duan;Z. Sheng;K. Xu

  • Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike.

    Lihong Liu;Pengfei Wang;Manoj S Nair;Jian Yu

  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

    Kai Xu;Priyamvada Acharya;Rui Kong;Cheng Cheng

Frequent Co-Authors

Lawrence Shapiro
Lawrence Shapiro Columbia University
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
David D. Ho
David D. Ho Columbia University
John R. Mascola
John R. Mascola ModeX Therapeutics
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Yaoxing Huang
Yaoxing Huang Columbia University
Feng Li
Feng Li Shandong University
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Zizhang Sheng

Trending Scientists

Recently Published Articles